Folate and health - New knowledge and recommendations;Folat og helse - Ny kunnskap og nye anbefalinger

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 20, 1998, Pages 3155-3160

  Seppola, Grethe ^a   Stein, Tell ^a   Vollset, Emil ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; ATTITUDE TO HEALTH; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; NEURAL TUBE DEFECT; NORWAY; NUTRITIONAL REQUIREMENT; PRACTICE GUIDELINE; PREGNANCY; REVIEW;

ADULT; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GUIDELINES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NEURAL TUBE DEFECTS; NORWAY; NUTRITIONAL REQUIREMENTS; PREGNANCY;

EID: 0032581759     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Herbert V, Das KC. Folic acid and vitamin B12. I: Shils ME, Olson JA, Shike M, red. Modern nutrition in health and disease. 8. utg. Philadelphia: Lea & Febiger, 1994.
2. Vurdering av behovet for tilsetning av nasringsstoffer til matvarer beregnet for det norske marked. Oslo: Statens ernæringsråd, 1994.
3. Vurdering av behovet for økt folatinntak. Statens ernæringsråds rapport nr. 2/1997. Oslo: Statens ernæringsråd, 1997.
4. Anbefalinger og virkemidler for økt folatinntak blant kvinner i fertil alder. Statens ernæringsråds rapport nr. 1/1998. Oslo: Statens ernæringsråd, 1998.
5. Rimestad AH, Blaker B, Plåten A-M, Nordbotten A. Den store matvaretabellen 1995. Oslo: Universitetsforlaget, 1995.
6. Nylenna M, red. Skikk og bruk i Tidsskriftet. Oslo: Tidsskrift for Den norske lægeforening, 1997: 49.
7. National Research Council. Recommended dietary allowances. 10. utg. Washington D.C.: National Academy Press, 1989.
8. Nordisk Ministerrad, Nordiska Näringsrekommendationer 1996. Näringsforskning 1996; 40: 161-5.
9. Jacob RA, Wu M-M, Henning SM, Swendseid ME. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr 1994; 124: 1072-80.
10. O'Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA, Cerda JJ et al. Controlled dietary folate affects folate status in nonpregnant women. JNutr 1995; 125:2717-25.
11. Norske næingsstoffanbefalinger. Oslo: Statens ernæringsråd, 1997.
12. Bailey LB. Folate in health and disease. New York: Marcel Dekker, 1995.
13. Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ. Results of an international round robin for serum and whole-blood folate. Clin Chem 1996; 42: 1689-94.
14. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316: 894-8.
15. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum. Methods and clinical applications. Clin Chem 1993; 39: 1764-79.
16. Campbell NRC. How safe are folic acid supplements? Arch Intern Med 1996; 156: 1638-44.
17. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
18. Omenn OS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5.
19. Roe DA. Drug-folate interrelationships: historical aspects and current concerns. I: Picciano MF, Stockstad ELR, Gregory JF, red. Folic acid metabolism in health and disease. New York: Wiley-Liss, 1990: 277-87.
20. Simmer K, lies CA, James C, Thompson RPH. Are iron-folate supplements harmful? Am J Clin Nutr 1987; 45: 122-5.
21. Johansson L, Sol voll K, Bjørneboe G-EA, Drevon CA. Dietary habits among Norwegian men and women. Scand J Nutr 1997; 41: 63-70.
22. Harper P. Practical genetic counselling. 4. utg. Oxford: Butterworth & Heinemann, 1993: 177.
23. Meadow R. Anticonvulsants in pregnancy. Arch Dis Child 1991; 66: 62-5.
24. A Report from The International Clearinghouse for Birth Defects Monitoring Systems. Congenital malformations worldwide. Amsterdam: Elsevier, 1991.
25. Conway H. Effect of supplemental vitamin therapy on the limitation of incidence of cleft lip and cleft palate in humans. Plast Reconstr Surg 1958; 22: 450-3.
26. Hibbard BM. The role of folic acid in pregnancy with particular reference to anemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964; 71: 529-42.
27. Vollset SE, Irgens LM. Folinsyre og svangerskap - sikker kunnskap, usikker praksis. Tidsskr Nor Lægeforen 1996; 116: 217-8.
28. Christensen B. Folatmangel, kreft og medfødte misdannelser. Tidsskr Nor Lægeforen 1996; 116: 250-4.
29. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991:338: 131-7.
30. Czeizel AE, Dudas 1. Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5.
31. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996; 98: 911-7.
32. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995; 6: 212-8.
33. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995; 346: 393-6.
34. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993; 306: 1645-8.
35. Wessel TAWG, Wouters MGAJ, Van der Molen EF, Spuijbroek MDEH, SteegersTheunissen RPM, Blom HJ et al. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gyn Repr Biol 1996; 66: 23-9.
36. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm OF et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993; 60: 820-5.
37. Baumslag N, Edelstein T, Metz J. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. BMJ 1970; 1: 16-7.
38. lyengar L, Rajalakshmi K. Effect of folic acid supplementation on birth weights of infants. Am J Obstet Gynecol 1975; 122: 332-6.
39. Hook EB, Czeizel AE. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects? Lancet 1997; 350: 513-5.
40. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993; 88: 1463-9.
41. Guttormsen AB, Ueland PM, Nesthus I, Nygârd O, Schneede J, Vollset SE et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥ 40 μmol/L). The Hordaland Homocysteine Study. J Clin Invest 1996; 98: 2174-83.
42. Ou CY, Stevenson RE, Brown VK. Schwartz CE, Allen WP, Khoury MJ et al. 5,10 méthylène-tetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-4.
43. Van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
44. Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996; 58: 17-9.
45. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359-64.
46. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
47. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE et al.The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985; 37: 1-31.
48. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
49. Welch ON, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-50.
50. Nygârd O. The Hordaland homocysteine studies. Determinants and prognostic value of plasma total homocysteine. Doktoravhandling. Bergen: Institutt for samfunnsmedisinske fag, Universitetet i Bergen, 1998.
51. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-6.
52. Brattström L. Vitamins as homocysteinelowering agents. J Nutr 1996; 126: 1276-80.
53. Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998; 90: 57-62.
54. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102.
55. Slattery ML, Schaffer D, Edwards SL, Ma KN, Potter JD. Are dietary factors involved in DNA methylation associated with colon cancer? Nutr Cancer 1997; 28: 52-62.
56. Riggs KM, Spiro A 3rd, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63: 306-14.
57. Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry 1997; 38: 305-14.
58. Cornell MC, Erickson JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly. Teratology 1997; 55: 134-7.
59. Folic acid fortification. Nutr Rev 1996; 54: 94-5.
60. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity oi high vitamin A intake. N Engl J Med 1995; 333: 1369-73. O